UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

British journal of dermatology (1951), 2016-11, Vol.175 (5), p.1073-1075

2016

Volltextzugriff (PDF)

Sotrastaurin in Calcineurin Inhibitor–Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients

American journal of transplantation, 2013-07, Vol.13 (7), p.1757-1768

2013

Volltextzugriff (PDF)

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

Transplantation, 2009-01, Vol.87 (2), p.233-242

2009

Volltextzugriff (PDF)

Drug points: Premature osteonecrosis and sirolimus treatment in renal transplantation

BMJ, 2001-09, Vol.323 (7314), p.665-665

2001

Volltextzugriff (PDF)

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

Transplantation, 2001-09, Vol.72 (5), p.777

2001

Volltextzugriff (PDF)

Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

European journal of clinical pharmacology, 2000-08, Vol.56 (5), p.395-398

2000

Volltextzugriff (PDF)

Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study

American journal of transplantation, 2010-12, Vol.10 (12), p.2632-2643

2010

Volltextzugriff (PDF)

Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients

Transplantation proceedings, 2003-05, Vol.35 (3), p.S115-S117

2003

Volltextzugriff (PDF)

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6‐Month Safety and Efficacy Results of Two Randomized Studies

American journal of transplantation, 2004-04, Vol.4 (4), p.626-635

2004

Volltextzugriff (PDF)

Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement

Medical journal of Australia, 2005-08, Vol.183 (3), p.138-141

Mathew, Timothy H

2005

Volltextzugriff (PDF)

12‐month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients

Transplant international, 2007-01, Vol.20 (1), p.27-36

2007

Volltextzugriff (PDF)

Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function

Transplantation, 2005-11, Vol.80 (9), p.1204-1211

2005

Volltextzugriff (PDF)

Human papillomavirus in the oral cavity of patients with and without renal transplantation

Transplantation, 2006-08, Vol.82 (4), p.570-573

2006

Volltextzugriff (PDF)

Australian nephrologists' attitudes towards living kidney donation

Nephrology, dialysis, transplantation, 2006-05, Vol.21 (5), p.1178-1183

2006

Volltextzugriff (PDF)

Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial

Transplantation, 2003-04, Vol.75 (8), p.1277

2003

Volltextzugriff (PDF)

Two cases of delayed cyclosporin absorption leading to CsA exposure higher than that predicted by C2 monitoring alone

Nephrology, dialysis, transplantation, 2005-08, Vol.20 (8), p.1745-1747

2005

Volltextzugriff (PDF)

The man who gained a stone

Nephrology, dialysis, transplantation, 2003-02, Vol.18 (2), p.434-435

2003

Volltextzugriff (PDF)

Graft loss following renal transplantation in Australia: is there a centre effect?

Nephrology, dialysis, transplantation, 2002-06, Vol.17 (6), p.1099-1104

2002

Volltextzugriff (PDF)

Expression of growth arrest-specific gene 6 and its receptors in dysfunctional human renal allografts

Transplant international, 2003-09, Vol.16 (9), p.681-688

2003

Volltextzugriff (PDF)

A Trial of Extending Hemodialysis Hours and Quality of Life

Journal of the American Society of Nephrology, 2017-06, Vol.28 (6), p.1898-1911

2017

Volltextzugriff (PDF)

Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey

Circulation (New York, N.Y.), 2019-10, Vol.140 (14), p.1156-1169

2019

Volltextzugriff (PDF)

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice

Neurology, 2019-04, Vol.92 (15), p.e1724

2019

Volltextzugriff (PDF)

Long-Term Cancer Risk of Immunosuppressive Regimens after Kidney Transplantation

Journal of the American Society of Nephrology, 2010-05, Vol.21 (5), p.852-858

2010

Volltextzugriff (PDF)

Novel Once‐Daily Extended‐Release Tacrolimus (LCPT) Versus Twice‐Daily Tacrolimus in De Novo Kidney Transplants: One‐Year Results of Phase III, Double‐Blind, Randomized Trial

American journal of transplantation, 2014-12, Vol.14 (12), p.2796-2806

2014

Volltextzugriff (PDF)

Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial

American journal of kidney diseases, 2016-04, Vol.67 (4), p.648-659

2016

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(34)
Male
(33)
Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Adult
(31)
Female
(31)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Transplantation
(19)
Aged
(18)
Surgery
(16)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(13)
Kidney Transplantation
(12)
Immunosuppressive Agents - Administration & Dosage
(11)
Adolescent
(9)
Surgery Of The Urinary System
(9)
Time Factors
(9)
Treatment Outcome
(9)
Sirolimus - Administration & Dosage
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

Sotrastaurin in Calcineurin Inhibitor–Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

Drug points: Premature osteonecrosis and sirolimus treatment in renal transplantation

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study

Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6‐Month Safety and Efficacy Results of Two Randomized Studies

Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement

12‐month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients

Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function

Human papillomavirus in the oral cavity of patients with and without renal transplantation

Australian nephrologists' attitudes towards living kidney donation

Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial

Two cases of delayed cyclosporin absorption leading to CsA exposure higher than that predicted by C2 monitoring alone

The man who gained a stone

Graft loss following renal transplantation in Australia: is there a centre effect?

Expression of growth arrest-specific gene 6 and its receptors in dysfunctional human renal allografts

A Trial of Extending Hemodialysis Hours and Quality of Life

Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice

Long-Term Cancer Risk of Immunosuppressive Regimens after Kidney Transplantation

Novel Once‐Daily Extended‐Release Tacrolimus (LCPT) Versus Twice‐Daily Tacrolimus in De Novo Kidney Transplants: One‐Year Results of Phase III, Double‐Blind, Randomized Trial

Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial

Aktive Filter

Suchergebnisse filtern